MMP-1/2 and TIMP-1/2 expression levels, and the levels of collagenous and elastic fibers correlate with disease progression in a hamster model of tongue cancer

Fan,Haixia; Jiang,Wenhao; Li,Haixia; Fang,Ming; Xu,Yudong; Zheng,Jinhua

doi:10.3892/ol.2015.3837

MMP-1/2 and TIMP-1/2 expression levels, and the levels of collagenous and elastic fibers correlate with disease progression in a hamster model of tongue cancer

Authors:
- Haixia Fan
- Wenhao Jiang
- Haixia Li
- Ming Fang
- Yudong Xu
- Jinhua Zheng
View Affiliations

Affiliations: Department of Anatomy, Basic Medical Science College, Harbin Medical University, Harbin, Heilongjiang 150081, P.R. China
Published online on: October 29, 2015 https://doi.org/10.3892/ol.2015.3837
Pages: 63-68
Copyright: © Fan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

In the present study, the presence of extracellular matrix components, including collagenous and elastic fibers, and the expression of their key regulating enzymes, were investigated in different stages of hamster tongue carcinoma development. Immunohistochemical and computer‑assisted morphological analyses were performed to quantify the staining intensity and area (integral optical density) of matrix metalloproteinase (MMP)‑1 and ‑2, tissue inhibitors of metalloproteinase (TIMP)‑1 and ‑2, and the extent of elastic and collagenous fibers in histological sections. MMP‑1, MMP‑2, TIMP‑1 and TIMP‑2 expression levels gradually increased with tongue cancer progression, and were associated with disease pathology staging (r=0.705, 0.633, 0.759 and 0.751, respectively). By contrast, elastic fiber levels gradually decreased with cancer progression and were negatively correlated with disease staging (r=‑0.881). The levels of collagenous fibers gradually increased with cancer progression and showed a positive correlation (r=0.619). In summary, the study demonstrated that MMP1/2 and TIMP1/2 expression levels, and collagenous and elastic fiber levels were significantly correlated with disease progression in a hamster model of tongue cancer.

View Figures

View References

1	Souza LF, Souza VF, Silva LD, Santos JN and Reis SR: Expression of basement membrane laminin in oral squamous cell carcinomas. Braz J Otorhinolaryngol. 73:768–774. 2007. View Article : Google Scholar : PubMed/NCBI
2	Sakamoto S and Kyprianou N: Targeting anoikis resistance in prostate cancer metastasis. Mol Aspects Med. 31:205–214. 2010. View Article : Google Scholar : PubMed/NCBI
3	Rajalalitha P and Vali S: Molecular pathogenesis of oral submucous fibrosis-a collagenous metabolic disorder. J Oral Pathol Med. 34:321–328. 2005. View Article : Google Scholar : PubMed/NCBI
4	Reichart PA, van Wyk CW, Becker J and Schuppan D: Distribution of procollagenous type III, collagenous type VI and tenascin in oral submucous fibrosis (OSF). J Oral Pathol Med. 23:394–398. 1994. View Article : Google Scholar : PubMed/NCBI
5	Lin HJ and Lin JC: Treatment of oral submucous fibrosis by collagenousase: Effects on oral opening and eating function. Oral Dis. 13:407–413. 2007. View Article : Google Scholar : PubMed/NCBI
6	Sumeth Perera MW, Gunasinghe D, Perera PA, Ranasinghe A, Amaratunga P, Warnakulasuriya S and Kaluarachchi K: Development of an in vivo mouse model to study oral submucous fibrosis. J Oral Pathol Med. 36:273–280. 2007. View Article : Google Scholar : PubMed/NCBI
7	Kerkelä E and Saarialho-Kere U: Matrix metalloproteinases in tumor progression: Focus on basal and squamous cell skin cancer. Exp Dermatol. 12:109–125. 2003. View Article : Google Scholar : PubMed/NCBI
8	Egeblad M and Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2:161–174. 2002. View Article : Google Scholar : PubMed/NCBI
9	Stamenkovic I: Matrix metalloproteinases in tumor invasion and metastasis. Semin Cancer Biol. 10:415–433. 2000. View Article : Google Scholar : PubMed/NCBI
10	Sorsa T, Tjäderhane L and Salo T: Matrix metalloproteinases (MMPs) in oral diseases. Oral Dis. 10:311–318. 2004. View Article : Google Scholar : PubMed/NCBI
11	Kessenbrock K, Plaks V and Werb Z: Matrix metalloproteinases: Regulators of the tumor microenvironment. Cell. 141:52–67. 2010. View Article : Google Scholar : PubMed/NCBI
12	Roy R, Yang J and Moses MA: Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J Clin Oncol. 27:5287–5297. 2009. View Article : Google Scholar : PubMed/NCBI
13	Seguier S, Gogly B, Bodineau A, Godeau G and Brousse N: Is collagenous breakdown during periodontitis linked to inflammatory cells and expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gingival tissue? J Periodontol. 72:1398–1406. 2001. View Article : Google Scholar : PubMed/NCBI
14	Stetler-Stevenson WG: Tissue inhibitors of metalloproteinases in cell signaling: Metalloproteinase-independent biological activities. Sci Signal. 1:re62008. View Article : Google Scholar : PubMed/NCBI
15	Boire A, Covic L, Agarwal A, Jacques S, Sherifi S and Kuliopulos A: PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell. 120:303–313. 2005. View Article : Google Scholar : PubMed/NCBI
16	George A, Ranganathan K and Rao UK: Expression of MMP-1 in histopathological different grades of oral squamous cell carcinoma and in normal buccal mucosa-an immunohistochemical study. Cancer Biomark. 7:275–283. 2010.PubMed/NCBI
17	Zhou J, Brinckerhoff C, Lubert S, et al: Analysis of matrix metalloproteinase-1 gene polymorphisms and expression in benign and malignant breast tumors. Cancer Invest. 29:599–607. 2011. View Article : Google Scholar : PubMed/NCBI
18	Durlik M and Gardian K: Metalloproteinase 2 and 9 activity in the development of pancreatic cancer. Pol Przegl Chir. 84:377–382. 2012.PubMed/NCBI
19	Itoh T, Tanioka M, Yoshida H, Yoshioka T, Nishimoto H and Itohara S: Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res. 58:1048–1051. 1998.PubMed/NCBI
20	Uhlmann ME, Georgieva M, Sill M, Linnemann U and Berger MR: Prognostic value of tumor progression-related gene expression in colorectal cancer patients. J Cancer Res Clin Oncol. 138:1631–1640. 2012. View Article : Google Scholar : PubMed/NCBI
21	Wang J and Cai Y: Matrix metalloproteinase 2 polymorphisms and expression in lung cancer: A meta-analysis. Tumour Biol. 33:1819–1828. 2012. View Article : Google Scholar : PubMed/NCBI
22	Zhang M, Teng XD, Guo XX, Li ZG, Han JG and Yao L: Expression of tissue levels of matrix metalloproteinases and their inhibitors in breast cancer. Breast. 22:330–334. 2013. View Article : Google Scholar : PubMed/NCBI
23	Kurahara S, Shinohara M, Ikebe T, et al: Expression of MMPS, MT-MMP and TIMPs in squamous cell carcinoma of the oral cavity: Correlations with tumor invasion and metastasis. Head Neck. 21:627–638. 1999. View Article : Google Scholar : PubMed/NCBI
24	Nakano K, Siar CH, Nagai N, et al: Distribution of basement membrane type IV collagenous alpha chains in ameloblastoma: An immunofluorescence study. J Oral Pathol Med. 31:494–499. 2002. View Article : Google Scholar : PubMed/NCBI
25	Bourboulia D and Stetler-Stevenson WG: Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion. Semin Cancer Biol. 20:161–168. 2010. View Article : Google Scholar : PubMed/NCBI
26	Hojilla CV, Mohammed FF and Khokha R: Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development. Br J Cancer. 89:1817–1821. 2003. View Article : Google Scholar : PubMed/NCBI
27	Stetler-Stevenson WG: The tumor microenvironment: Regulation by MMP-independent effects of tissue inhibitor of metalloproteinases-2. Cancer Metastasis Rev. 27:57–66. 2008. View Article : Google Scholar : PubMed/NCBI
28	Nagase H: Activation mechanisms of matrix metalloproteinases. Biol Chem. 378:151–160. 1997.PubMed/NCBI
29	Stetler-Stevenson WG, Krutzsch HC and Liotta LA: Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family. J Biol Chem. 264:17374–17378. 1989.PubMed/NCBI
30	Pradhan-Palikhe P, Vesterinen T, Tarkkanen J, et al: Plasma level of tissue inhibitor of matrix metalloproteinase-1 but not that of matrix metalloproteinase-8 predicts survival in head and neck squamous cell cancer. Oral Oncol. 46:514–518. 2010. View Article : Google Scholar : PubMed/NCBI
31	Burduk PK, Bodnar M, Sawicki P, et al: Expression of metalloproteinases 2 and 9 and tissue inhibitors 1 and 2 as predictors of lymph node metastases in oropharyngeal squamous cell carcinoma. Head Neck. 37:418–422. 2015. View Article : Google Scholar : PubMed/NCBI
32	Giaginis C, Nikiteas N, Margeli A, et al: Serum tissue inhibitor of metalloproteinase 1 and 2 (TIMP-1 and TIMP-2) levels in colorectal cancer patients: Associations with clinicopathological variables and patient survival. Int J Biol Markers. 24:245–252. 2009.PubMed/NCBI
33	Chen D, Zheng J, Li H, Wang Q and Jiao X: Computer-assisted morphometric analysis of lymphatic vessel changes in hamster tongue carcinogenesis. J Oral Pathol Med. 39:518–524. 2010.PubMed/NCBI
34	Thompson L: World health organization classification of tumours: Pathology and genetics of head and neck tumours. Ear Nose Throat J. 85:742006.PubMed/NCBI
35	Chatterjee S, Mark ME, Wooley PH, et al: Increased dermal elastic fibers in the tight skin mouse. Clin Exp Rheumatol. 22:617–620. 2004.PubMed/NCBI
36	Ali FM, Patil A, Patil K and Prasant MC: Oral submucous fibrosis and its dermatological relation. Indian Dermatol Online J. 5:260–265. 2014. View Article : Google Scholar : PubMed/NCBI
37	Hong Q, Jun T, Lei J, Xiling J and Tamamura R: Expression and clinical significance of matrix metalloproteinase-2 and its inhibitor TIMP-2 in oral squamous cell carcinoma. J Hard Tissue Biol. 2:54–60. 2006. View Article : Google Scholar
38	Santos-García A, Abad-Hernández MM, Fonseca-Sánchez E, Julián-González R, Galindo-Villardón P, Cruz-Hernández JJ and Bullón-Sopelana A: E-cadherin, laminin and collagenous IV expression in the evolution from dysplasia to oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal. 11:E100–E105. 2006.(In Spanish). PubMed/NCBI
39	Utsunomiya H, Tilakaratne WM, Oshiro K, et al: Extracellular matrix remodeling in oral submucous fibrosis: Its stage-specific modes revealed by immunohistochemistry and in situ hybridization. J Oral Pathol Med. 34:498–507. 2005. View Article : Google Scholar : PubMed/NCBI
40	Krecicki T, Zalesska-Krecicka M, Jelen M, et al: Expression of type IV collagenous and matrix metalloproteinase-2 (type IV collagenousase) in relation to nodal status in laryngeal cancer. Clin Otolaryngol Allied Sci. 26:469–472. 2001. View Article : Google Scholar : PubMed/NCBI
41	Lazaris ACH, Tzoumani AN, Thimara I, et al: Immunohistochemical assessment of basement membrane components in colorectal cancer: prognostic implications. J Exp Clin Cancer Res. 22:599–606. 2003.PubMed/NCBI
42	Shieh TY and Yang JF: Collagenousase activity in oral submucous fibrosis. Proc Natl Sci Counc Repub China B. 16:106–110. 1992.PubMed/NCBI
43	Yen CY, Chen CH, Chang CH, et al: Matrix metalloproteinases (MMP) 1 and MMP10 but not MMP12 are potential oral cancer markers. Biomarkers. 14:244–249. 2009. View Article : Google Scholar : PubMed/NCBI